TOP TIERMARKET NEWSWIRE
News & sentiment

TAYSHA GENE THERAPIE (TSHA) — News & AI sentiment

TAYSHA GENE THERAPIE (TSHA) news roundup. 4 stories aggregated over the last 30 days. Average 30-day sentiment is 56.5/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
4
avg sentiment 56.5/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

TSHA news in the last 24 hours, 7 days, 30 days and 90 days

How much TSHA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowTSHA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days456.5/100TSHA headlines →
Last 90 days2453.6/100TSHA headlines →

Latest stories on TSHA

Oct 2
Oct 2
Oct 1
Oct 1
Sep 17
Sep 11
Sep 7
Sep 7
Sep 4
Sep 4
Aug 24
Taysha Gene Therapies (TSHA) Q2 2026 Earnings Call
The Motley Fool73 · bullishearnings
Aug 18
Why is Taysha Gene Therapies stock sliding today?
Investing.com Markets34 · bearishgeneral
Aug 12
Aug 12
Aug 12
Aug 11
Aug 11
Aug 11
Aug 11
Aug 11
Taysha Gene Therapies Q2 2026 Earnings Preview
Seeking Alpha34 · bearishearnings
Aug 10
Aug 7
Aug 4
Aug 3
Jul 15
Open TSHA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →